VECTOKA REPORT AT NAM SAI GON INTERNATIONAL GENERAL HOSPITAL

On June 20, 2020, Medbolide Pharmaceutical JSC held a presentation on VECTOKA (2% Troxerutin gel) at Nam Saigon International General Hospital.

The presentation was attended by 30 doctors and medical staff currently working at the hospital.

Company representatives presented recommendations and clinical studies demonstrating the efficacy of Troxerutin in alleviating symptoms associated with venous insufficiency, injuries, sprains, and dislocations. Following the presentation, the doctors engaged in extensive discussions and expressed interest in VECTOKA (2% Troxerutin gel). This is considered a new solution for the topical treatment of chronic venous insufficiency, as well as the proper use and safety profile of VECTOKA.

In closing the report, Medbolide Pharmaceutical JSC expressed its gratitude and looked forward to continuing to partner with Nam Saigon International General Hospital in providing solutions to improve patients’ quality of life.